Open AccessSex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis
Author(s) -
Philip H. Smith,
Andrea H. Weinberger,
Ju Zhang,
Erin Emme,
Carolyn M. Mazure,
Sherry A. McKee
Publication year - 2016
Publication title -
nicotine and tobacco research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.338
H-Index - 113
eISSN - 1469-994X
pISSN - 1462-2203
DOI - 10.1093/ntr/ntw144
Subject(s) - varenicline , bupropion , smoking cessation , medicine , placebo , meta analysis , randomized controlled trial , pharmacotherapy , nicotine replacement therapy , psychiatry , alternative medicine , pathology
Converging clinical and biological evidence suggest sex is an important factor when selecting a pharmacological intervention for smoking cessation. The current investigation used network meta-analyses to estimate sex differences in the comparative efficacy of transdermal nicotine (TN), varenicline, and sustained release (SR) bupropion for smoking cessation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom